| dc.contributor.author | Mukerebe, Crispin | |
| dc.contributor.author | Cordeiro, Alexandra | |
| dc.contributor.author | Aristide, Christine | |
| dc.contributor.author | Colombe, Soledad | |
| dc.contributor.author | Bullington, Brooke | |
| dc.contributor.author | Kalluvya, Samuel | |
| dc.contributor.author | Dam, Govert | |
| dc.contributor.author | de Dood, Claudia | |
| dc.contributor.author | Corstjens, Paul | |
| dc.contributor.author | Maganga, Jane | |
| dc.contributor.author | Changalucha, John | |
| dc.contributor.author | Namkinga, Lucy | |
| dc.contributor.author | Makene, Victor | |
| dc.contributor.author | Lee, Myung | |
| dc.contributor.author | Downs, Jennifer | |
| dc.date.accessioned | 2026-06-10T11:49:41Z | |
| dc.date.available | 2026-06-10T11:49:41Z | |
| dc.date.issued | 2026 | |
| dc.identifier.citation | Mukerebe C, Cordeiro AA, Aristide C, Colombe S, Bullington BW, Kalluvya S, van Dam GJ, de Dood CJ, Corstjens PL, Maganga JK, Changalucha JM. Schistosome infection is associated with high-risk Human Papillomavirus persistence, together with altered cervicovaginal microbiota. The Journal of infectious diseases. 2026 Feb 15;233(2):375-80. | en_US |
| dc.identifier.uri | http://41.93.38.5:8080/xmlui/handle/123456789/149 | |
| dc.description.abstract | Schistosoma haematobium infection may impair female genital mucosal antiviral defense. We sought to determine whether women with S. haematobium infection had higher odds of high-risk human papillomavirus (HR-HPV) persistence, a pre-requisite to cervical cancer. We also examined cervicovaginal dysbiosis, which has been linked to HR-HPV persistence and schistosome infection. In 96 Tanzanian women with baseline and 9–12-month follow-up samples, we performed HPV genotyping, schistosome antigen quantification, and 16S rRNA sequencing. Both S. haematobium (Odds ratio (OR): 4.7 [1.3–16.5], p=0.017) and Gardnerella-dominant microbiome (p=0.049) were associated with HR-HPV persistence, suggesting these factors may contribute to high cervical cancer rates in Africa. | en_US |
| dc.description.sponsorship | The National Institutes of Health / National Institute of Allergy and Infectious Diseases (R01 AI 168306 and K24 AI 182638) and by the Fogarty International Center (D43 TW 011826). | en_US |
| dc.language.iso | en | en_US |
| dc.relation.ispartofseries | HHS Public Access; | |
| dc.subject | S. haematobium, | en_US |
| dc.subject | high-risk human papillomavirus; | en_US |
| dc.subject | cervicovaginal dysbiosis. | en_US |
| dc.title | Schistosome Infection is Associated with High-Risk Human Papillomavirus Persistence, Together with Altered Cervicovaginal Microbiota | en_US |
| dc.type | Article | en_US |